AGEPX | EIDOX | AGEPX / EIDOX | |
Total Expense Ratio | 1.40 | 0.91 | 154% |
Annual Report Gross Expense Ratio | 1.40 | 0.91 | 154% |
Fund Existence | 12 years | 10 years | - |
Gain YTD | 13.499 | 11.921 | 113% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.24B | 3.9B | 32% |
Annual Yield % from dividends | 10.52 | 8.14 | 129% |
Returns for 1 year | 16.07 | 14.77 | 109% |
Returns for 3 years | 60.42 | 54.35 | 111% |
Returns for 5 years | 47.05 | 41.32 | 114% |
Returns for 10 years | 94.39 | 100.64 | 94% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LYFCX | 14.17 | 0.09 | +0.64% |
AlphaCentric Life Sciences & Hlthcare C | |||
PLGAX | 16.54 | 0.09 | +0.55% |
Principal LargeCap Growth I A | |||
NQVCX | 55.74 | 0.27 | +0.49% |
Nuveen Multi Cap Value C | |||
IYBIX | 25.96 | 0.07 | +0.27% |
Macquarie Balanced Fund Class I | |||
EMEAX | 14.19 | -0.06 | -0.42% |
Ashmore Emerging Markets Equity A |